Ocular	B:C1262036
toxicity	I:C1262036
of	O
AUY922	O
in	O
pigmented	O
and	O
albino	O
rats	O
.	O

Ocular	O
toxicity	I:C1262036
of	O
AUY922	B:C2348996
in	O
pigmented	O
and	O
albino	O
rats	O
.	O

Ocular	O
toxicity	I:C1262036
of	O
AUY922	O
in	O
pigmented	B:C0034700
and	O
albino	O
rats	O
.	O

AUY922	B:C2348996
,	O
a	O
heat	O
shock	I:C0243044
protein	I:C0243044
90	I:C0243044
inhibitor	O
is	O
associated	O
with	O
ocular	O
adverse	O
events	I:C0877248
(	O
adverse	O
events	I:C0877248
)	O
.	O

AUY922	O
,	O
a	O
heat	B:C0243044
shock	I:C0243044
protein	I:C0243044
90	I:C0243044
inhibitor	O
is	O
associated	O
with	O
ocular	O
adverse	O
events	I:C0877248
(	O
adverse	O
events	I:C0877248
)	O
.	O

AUY922	O
,	O
a	O
heat	O
shock	I:C0243044
protein	I:C0243044
90	I:C0243044
inhibitor	O
is	O
associated	O
with	O
ocular	B:C0015392
adverse	O
events	I:C0877248
(	O
adverse	O
events	I:C0877248
)	O
.	O

AUY922	O
,	O
a	O
heat	O
shock	I:C0243044
protein	I:C0243044
90	I:C0243044
inhibitor	O
is	O
associated	O
with	O
ocular	O
adverse	B:C0877248
events	I:C0877248
(	O
adverse	O
events	I:C0877248
)	O
.	O

AUY922	O
,	O
a	O
heat	O
shock	I:C0243044
protein	I:C0243044
90	I:C0243044
inhibitor	O
is	O
associated	O
with	O
ocular	O
adverse	O
events	I:C0877248
(	O
adverse	B:C0877248
events	I:C0877248
)	O
.	O

To	O
provide	O
a	O
better	O
understanding	O
of	O
ocular	B:C0015392
adverse	O
events	I:C0877248
in	O
patients	O
,	O
4	O
investigative	O
studies	I:C2603343
were	O
performed	O
in	O
a	O
step	O
-	I:C0449445
wise	I:C0449445
approach	I:C0449445
to	O
assess	O
retinal	O
structure	I:C0035298
and	O
function	O
in	O
pigmented	O
(	O
Brown	O
Norway	I:C0034700
)	O
and	O
albino	O
(	O
Wistar	O
)	O
rats	O
.	O

To	O
provide	O
a	O
better	O
understanding	O
of	O
ocular	O
adverse	B:C0877248
events	I:C0877248
in	O
patients	O
,	O
4	O
investigative	O
studies	I:C2603343
were	O
performed	O
in	O
a	O
step	O
-	I:C0449445
wise	I:C0449445
approach	I:C0449445
to	O
assess	O
retinal	O
structure	I:C0035298
and	O
function	O
in	O
pigmented	O
(	O
Brown	O
Norway	I:C0034700
)	O
and	O
albino	O
(	O
Wistar	O
)	O
rats	O
.	O

To	O
provide	O
a	O
better	O
understanding	O
of	O
ocular	O
adverse	O
events	I:C0877248
in	O
patients	O
,	O
4	O
investigative	B:C2603343
studies	I:C2603343
were	O
performed	O
in	O
a	O
step	O
-	I:C0449445
wise	I:C0449445
approach	I:C0449445
to	O
assess	O
retinal	O
structure	I:C0035298
and	O
function	O
in	O
pigmented	O
(	O
Brown	O
Norway	I:C0034700
)	O
and	O
albino	O
(	O
Wistar	O
)	O
rats	O
.	O

To	O
provide	O
a	O
better	O
understanding	O
of	O
ocular	O
adverse	O
events	I:C0877248
in	O
patients	O
,	O
4	O
investigative	O
studies	I:C2603343
were	O
performed	O
in	O
a	O
step	B:C0449445
-	I:C0449445
wise	I:C0449445
approach	I:C0449445
to	O
assess	O
retinal	O
structure	I:C0035298
and	O
function	O
in	O
pigmented	O
(	O
Brown	O
Norway	I:C0034700
)	O
and	O
albino	O
(	O
Wistar	O
)	O
rats	O
.	O

To	O
provide	O
a	O
better	O
understanding	O
of	O
ocular	O
adverse	O
events	I:C0877248
in	O
patients	O
,	O
4	O
investigative	O
studies	I:C2603343
were	O
performed	O
in	O
a	O
step	O
-	I:C0449445
wise	I:C0449445
approach	I:C0449445
to	O
assess	O
retinal	B:C0035298
structure	I:C0035298
and	O
function	O
in	O
pigmented	O
(	O
Brown	O
Norway	I:C0034700
)	O
and	O
albino	O
(	O
Wistar	O
)	O
rats	O
.	O

To	O
provide	O
a	O
better	O
understanding	O
of	O
ocular	O
adverse	O
events	I:C0877248
in	O
patients	O
,	O
4	O
investigative	O
studies	I:C2603343
were	O
performed	O
in	O
a	O
step	O
-	I:C0449445
wise	I:C0449445
approach	I:C0449445
to	O
assess	O
retinal	O
structure	I:C0035298
and	O
function	O
in	O
pigmented	B:C0034700
(	O
Brown	O
Norway	I:C0034700
)	O
and	O
albino	O
(	O
Wistar	O
)	O
rats	O
.	O

To	O
provide	O
a	O
better	O
understanding	O
of	O
ocular	O
adverse	O
events	I:C0877248
in	O
patients	O
,	O
4	O
investigative	O
studies	I:C2603343
were	O
performed	O
in	O
a	O
step	O
-	I:C0449445
wise	I:C0449445
approach	I:C0449445
to	O
assess	O
retinal	O
structure	I:C0035298
and	O
function	O
in	O
pigmented	O
(	O
Brown	B:C0034700
Norway	I:C0034700
)	O
and	O
albino	O
(	O
Wistar	O
)	O
rats	O
.	O

To	O
provide	O
a	O
better	O
understanding	O
of	O
ocular	O
adverse	O
events	I:C0877248
in	O
patients	O
,	O
4	O
investigative	O
studies	I:C2603343
were	O
performed	O
in	O
a	O
step	O
-	I:C0449445
wise	I:C0449445
approach	I:C0449445
to	O
assess	O
retinal	O
structure	I:C0035298
and	O
function	O
in	O
pigmented	O
(	O
Brown	O
Norway	I:C0034700
)	O
and	O
albino	O
(	O
Wistar	B:C0034716
)	O
rats	O
.	O

In	O
rats	B:C0034721
administered	O
30	O
mg	O
/	O
kg	O
of	O
AUY922	O
,	O
the	O
AUC	O
0	O
-	O
24	O
h	O
and	O
Cmax	O
are	O
comparable	O
to	O
that	O
in	O
patients	O
at	O
70	O
mg	O
/	O
m(	O
2	O
)	O
.	O

In	O
rats	O
administered	O
30	O
mg	O
/	O
kg	O
of	O
AUY922	B:C2348996
,	O
the	O
AUC	O
0	O
-	O
24	O
h	O
and	O
Cmax	O
are	O
comparable	O
to	O
that	O
in	O
patients	O
at	O
70	O
mg	O
/	O
m(	O
2	O
)	O
.	O

AUY922	B:C2348996
at	O
≥	O
30	O
mg/kg	O
was	O
poorly	O
tolerated	O
by	O
rats	O
with	O
morbidity	O
or	O
mortality	O
generally	O
after	O
the	O
third	O
weekly	O
treatment	O
.	O

AUY922	O
at	O
≥	O
30	O
mg/kg	O
was	O
poorly	O
tolerated	O
by	O
rats	B:C0034721
with	O
morbidity	O
or	O
mortality	O
generally	O
after	O
the	O
third	O
weekly	O
treatment	O
.	O

AUY922	O
at	O
≥	O
30	O
mg/kg	O
was	O
poorly	O
tolerated	O
by	O
rats	O
with	O
morbidity	O
or	O
mortality	O
generally	O
after	O
the	O
third	O
weekly	O
treatment	B:C0087111
.	O

Electroretinography	B:C0013867
(	O
Electroretinography	O
)	O
changes	O
were	O
observed	O
at	O
doses	O
≥	O
30	O
mg	O
/	O
kg	O
.	O

Electroretinography	O
(	O
Electroretinography	B:C0013867
)	O
changes	O
were	O
observed	O
at	O
doses	O
≥	O
30	O
mg	O
/	O
kg	O
.	O

The	O
Electroretinography	B:C0013867
changes	O
were	O
dose	O
dependent	O
,	O
consistent	O
with	O
an	O
effect	O
on	O
the	O
photoreceptors	O
,	O
and	O
fully	O
reversible	O
.	O

The	O
Electroretinography	O
changes	O
were	O
dose	O
dependent	O
,	O
consistent	O
with	O
an	O
effect	O
on	O
the	O
photoreceptors	B:C0031760
,	O
and	O
fully	O
reversible	O
.	O

The	O
Electroretinography	B:C0013867
effects	O
could	O
not	O
be	O
minimized	O
by	O
decreasing	O
the	O
Cmax	O
while	O
maintaining	O
AUC	O
.	O

Histopathological	O
changes	O
were	O
seen	O
mainly	O
when	O
rats	B:C0034721
were	O
administered	O
AUY922	O
at	O
100	O
mg	O
/	O
kg	O
.	O

Histopathological	O
changes	O
were	O
seen	O
mainly	O
when	O
rats	O
were	O
administered	O
AUY922	B:C2348996
at	O
100	O
mg	O
/	O
kg	O
.	O

The	O
2	O
-	O
hour	O
infusion	B:C0574032
of	O
AUY922	O
at	O
100	O
mg	O
/	O
kg	O
caused	O
disorganization	O
of	O
the	O
outer	O
segment	I:C1325525
photoreceptor	I:C1325525
morphology	O
in	O
male	O
Brown	O
Norway	I:C0034700
rats	I:C0034700
;	O
the	O
severity	O
of	O
the	O
disorganization	O
increased	O
with	O
the	O
number	O
of	O
administrations	O
,	O
but	O
was	O
reversible	O
during	O
a	O
4	O
-	O
week	O
posttreatment	O
period	O
.	O

The	O
2	O
-	O
hour	O
infusion	O
of	O
AUY922	B:C2348996
at	O
100	O
mg	O
/	O
kg	O
caused	O
disorganization	O
of	O
the	O
outer	O
segment	I:C1325525
photoreceptor	I:C1325525
morphology	O
in	O
male	O
Brown	O
Norway	I:C0034700
rats	I:C0034700
;	O
the	O
severity	O
of	O
the	O
disorganization	O
increased	O
with	O
the	O
number	O
of	O
administrations	O
,	O
but	O
was	O
reversible	O
during	O
a	O
4	O
-	O
week	O
posttreatment	O
period	O
.	O

The	O
2	O
-	O
hour	O
infusion	O
of	O
AUY922	O
at	O
100	O
mg	O
/	O
kg	O
caused	O
disorganization	O
of	O
the	O
outer	B:C1325525
segment	I:C1325525
photoreceptor	I:C1325525
morphology	O
in	O
male	O
Brown	O
Norway	I:C0034700
rats	I:C0034700
;	O
the	O
severity	O
of	O
the	O
disorganization	O
increased	O
with	O
the	O
number	O
of	O
administrations	O
,	O
but	O
was	O
reversible	O
during	O
a	O
4	O
-	O
week	O
posttreatment	O
period	O
.	O

The	O
2	O
-	O
hour	O
infusion	O
of	O
AUY922	O
at	O
100	O
mg	O
/	O
kg	O
caused	O
disorganization	O
of	O
the	O
outer	O
segment	I:C1325525
photoreceptor	I:C1325525
morphology	O
in	O
male	O
Brown	B:C0034700
Norway	I:C0034700
rats	I:C0034700
;	O
the	O
severity	O
of	O
the	O
disorganization	O
increased	O
with	O
the	O
number	O
of	O
administrations	O
,	O
but	O
was	O
reversible	O
during	O
a	O
4	O
-	O
week	O
posttreatment	O
period	O
.	O

The	O
2	O
-	O
hour	O
infusion	O
of	O
AUY922	O
at	O
100	O
mg	O
/	O
kg	O
caused	O
disorganization	O
of	O
the	O
outer	O
segment	I:C1325525
photoreceptor	I:C1325525
morphology	O
in	O
male	O
Brown	O
Norway	I:C0034700
rats	I:C0034700
;	O
the	O
severity	O
of	O
the	O
disorganization	O
increased	O
with	O
the	O
number	O
of	O
administrations	B:C1533734
,	O
but	O
was	O
reversible	O
during	O
a	O
4	O
-	O
week	O
posttreatment	O
period	O
.	O

There	O
was	O
no	O
major	O
difference	O
in	O
ocular	B:C0015392
response	O
between	O
Brown	O
Norway	I:C0034700
and	O
Wistar	O
rats	I:C0034716
.	O

There	O
was	O
no	O
major	O
difference	O
in	O
ocular	O
response	O
between	O
Brown	B:C0034700
Norway	I:C0034700
and	O
Wistar	O
rats	I:C0034716
.	O

There	O
was	O
no	O
major	O
difference	O
in	O
ocular	O
response	O
between	O
Brown	O
Norway	I:C0034700
and	O
Wistar	B:C0034716
rats	I:C0034716
.	O

No	O
changes	O
in	O
serum	B:C0036810
iron	I:C0036810
levels	I:C0036810
,	O
and	O
no	O
changes	O
in	O
rhodopsin	O
,	O
PDE6α	O
,	O
β-	O
transducin	I:C0040665
concentrations	O
,	O
or	O
retinal	O
pigment	I:C1571376
epithelium	I:C1571376
-	I:C1571376
specific	I:C1571376
protein	I:C1571376
RPE65	I:C1571376
expression	O
were	O
observed	O
after	O
single	O
and	O
multiple	O
infusions	O
of	O
AUY922	O
at	O
100	O
mg	O
/	O
kg	O
compared	O
to	O
vehicle	O
-	O
treated	O
controls	O
.	O

No	O
changes	O
in	O
serum	O
iron	I:C0036810
levels	I:C0036810
,	O
and	O
no	O
changes	O
in	O
rhodopsin	B:C0035499
,	O
PDE6α	O
,	O
β-	O
transducin	I:C0040665
concentrations	O
,	O
or	O
retinal	O
pigment	I:C1571376
epithelium	I:C1571376
-	I:C1571376
specific	I:C1571376
protein	I:C1571376
RPE65	I:C1571376
expression	O
were	O
observed	O
after	O
single	O
and	O
multiple	O
infusions	O
of	O
AUY922	O
at	O
100	O
mg	O
/	O
kg	O
compared	O
to	O
vehicle	O
-	O
treated	O
controls	O
.	O

No	O
changes	O
in	O
serum	O
iron	I:C0036810
levels	I:C0036810
,	O
and	O
no	O
changes	O
in	O
rhodopsin	O
,	O
PDE6α	B:C1567350
,	O
β-	O
transducin	I:C0040665
concentrations	O
,	O
or	O
retinal	O
pigment	I:C1571376
epithelium	I:C1571376
-	I:C1571376
specific	I:C1571376
protein	I:C1571376
RPE65	I:C1571376
expression	O
were	O
observed	O
after	O
single	O
and	O
multiple	O
infusions	O
of	O
AUY922	O
at	O
100	O
mg	O
/	O
kg	O
compared	O
to	O
vehicle	O
-	O
treated	O
controls	O
.	O

No	O
changes	O
in	O
serum	O
iron	I:C0036810
levels	I:C0036810
,	O
and	O
no	O
changes	O
in	O
rhodopsin	O
,	O
PDE6α	O
,	O
β-	B:C0040665
transducin	I:C0040665
concentrations	O
,	O
or	O
retinal	O
pigment	I:C1571376
epithelium	I:C1571376
-	I:C1571376
specific	I:C1571376
protein	I:C1571376
RPE65	I:C1571376
expression	O
were	O
observed	O
after	O
single	O
and	O
multiple	O
infusions	O
of	O
AUY922	O
at	O
100	O
mg	O
/	O
kg	O
compared	O
to	O
vehicle	O
-	O
treated	O
controls	O
.	O

No	O
changes	O
in	O
serum	O
iron	I:C0036810
levels	I:C0036810
,	O
and	O
no	O
changes	O
in	O
rhodopsin	O
,	O
PDE6α	O
,	O
β-	O
transducin	I:C0040665
concentrations	O
,	O
or	O
retinal	B:C1571376
pigment	I:C1571376
epithelium	I:C1571376
-	I:C1571376
specific	I:C1571376
protein	I:C1571376
RPE65	I:C1571376
expression	O
were	O
observed	O
after	O
single	O
and	O
multiple	O
infusions	O
of	O
AUY922	O
at	O
100	O
mg	O
/	O
kg	O
compared	O
to	O
vehicle	O
-	O
treated	O
controls	O
.	O

No	O
changes	O
in	O
serum	O
iron	I:C0036810
levels	I:C0036810
,	O
and	O
no	O
changes	O
in	O
rhodopsin	O
,	O
PDE6α	O
,	O
β-	O
transducin	I:C0040665
concentrations	O
,	O
or	O
retinal	O
pigment	I:C1571376
epithelium	I:C1571376
-	I:C1571376
specific	I:C1571376
protein	I:C1571376
RPE65	I:C1571376
expression	B:C0017262
were	O
observed	O
after	O
single	O
and	O
multiple	O
infusions	O
of	O
AUY922	O
at	O
100	O
mg	O
/	O
kg	O
compared	O
to	O
vehicle	O
-	O
treated	O
controls	O
.	O

No	O
changes	O
in	O
serum	O
iron	I:C0036810
levels	I:C0036810
,	O
and	O
no	O
changes	O
in	O
rhodopsin	O
,	O
PDE6α	O
,	O
β-	O
transducin	I:C0040665
concentrations	O
,	O
or	O
retinal	O
pigment	I:C1571376
epithelium	I:C1571376
-	I:C1571376
specific	I:C1571376
protein	I:C1571376
RPE65	I:C1571376
expression	O
were	O
observed	O
after	O
single	O
and	O
multiple	O
infusions	B:C0574032
of	O
AUY922	O
at	O
100	O
mg	O
/	O
kg	O
compared	O
to	O
vehicle	O
-	O
treated	O
controls	O
.	O

No	O
changes	O
in	O
serum	O
iron	I:C0036810
levels	I:C0036810
,	O
and	O
no	O
changes	O
in	O
rhodopsin	O
,	O
PDE6α	O
,	O
β-	O
transducin	I:C0040665
concentrations	O
,	O
or	O
retinal	O
pigment	I:C1571376
epithelium	I:C1571376
-	I:C1571376
specific	I:C1571376
protein	I:C1571376
RPE65	I:C1571376
expression	O
were	O
observed	O
after	O
single	O
and	O
multiple	O
infusions	O
of	O
AUY922	B:C2348996
at	O
100	O
mg	O
/	O
kg	O
compared	O
to	O
vehicle	O
-	O
treated	O
controls	O
.	O

AUY922	B:C2348996
retinal	O
toxicity	I:C0877104
in	O
rats	O
recapitulates	O
and	O
further	O
characterizes	O
that	O
reported	O
in	O
patients	O
and	O
is	O
shown	O
to	O
be	O
reversible	O
,	O
while	O
a	O
precise	O
molecular	O
mechanism	I:C1258062
for	O
the	O
effect	O
was	O
not	O
determined	O
.	O

AUY922	O
retinal	B:C0877104
toxicity	I:C0877104
in	O
rats	O
recapitulates	O
and	O
further	O
characterizes	O
that	O
reported	O
in	O
patients	O
and	O
is	O
shown	O
to	O
be	O
reversible	O
,	O
while	O
a	O
precise	O
molecular	O
mechanism	I:C1258062
for	O
the	O
effect	O
was	O
not	O
determined	O
.	O

AUY922	O
retinal	O
toxicity	I:C0877104
in	O
rats	B:C0034721
recapitulates	O
and	O
further	O
characterizes	O
that	O
reported	O
in	O
patients	O
and	O
is	O
shown	O
to	O
be	O
reversible	O
,	O
while	O
a	O
precise	O
molecular	O
mechanism	I:C1258062
for	O
the	O
effect	O
was	O
not	O
determined	O
.	O

AUY922	O
retinal	O
toxicity	I:C0877104
in	O
rats	O
recapitulates	O
and	O
further	O
characterizes	O
that	O
reported	O
in	O
patients	O
and	O
is	O
shown	O
to	O
be	O
reversible	O
,	O
while	O
a	O
precise	O
molecular	B:C1258062
mechanism	I:C1258062
for	O
the	O
effect	O
was	O
not	O
determined	O
.	O

